-
Stay Connected
Get the latest news on exciting speakers, workshops & learning opportunities at ISDE 2021.
Subscribe for Updates
Advanced esophageal cancer can make swallowing difficult, painful, and unsafe. When surgery or curative treatment is no longer suitable, restoring the ability to eat and drink often becomes a central goal of care. An esophageal stent may provide rapid relief by holding the narrowed section of the esophagus open.
The use of stents in palliative care for esophageal cancer requires careful clinical judgment. A stent can improve swallowing within days, but it does not treat the underlying tumor. Its value depends on the patient’s prognosis, treatment plan, anatomy, nutritional needs, and priorities.
Education from specialist societies and congresses such as ISDE 2021 helps clinicians compare endoscopic techniques, review evidence, and understand how multidisciplinary teams manage malignant esophageal obstruction.
A self-expanding metal stent, commonly called a SEMS, is usually considered for significant dysphagia caused by an inoperable or recurrent esophageal tumor. It is particularly useful when a patient needs fast symptom relief or has a limited life expectancy in which slower treatments may not provide benefit soon enough.
Stenting can also help seal a malignant connection between the esophagus and airway or pleural space, such as an esophagorespiratory fistula. In these cases, a covered device may reduce leakage and aspiration, although airway assessment and coordinated specialist care are essential.
Stents are generally less suitable when curative surgery or definitive chemoradiotherapy is planned. They may interfere with later treatment, increase complications, or create technical difficulties during surgery. The oncology, gastroenterology, surgery, and palliative care teams should therefore agree on the treatment sequence before placement.
During endoscopy, the clinician guides a collapsed stent across the tumor-related narrowing, often with fluoroscopic imaging. Once released, the mesh expands and presses against the esophageal wall. Over several hours or days, the widened channel can make liquids and soft foods easier to swallow.
Most malignant obstruction is treated with a covered or partially covered metal stent. The covering helps limit tumor growth through the mesh and can support fistula closure. Uncovered stents may anchor more firmly, but tumor ingrowth can make later removal or replacement difficult.
Modern stents vary in diameter, length, flexibility, and anti-migration design. Accurate measurement matters: a device that is too short may fail to bridge the tumor, while excessive length can cause discomfort or affect the gastroesophageal junction.
The main benefit is prompt palliation of dysphagia. Better swallowing may allow oral nutrition, reduce dependence on feeding tubes, support social activities, and improve comfort. Stents can be especially valuable when radiotherapy would take too long to relieve symptoms or when a patient cannot tolerate a longer treatment course.
A stent does not eliminate pain, cure cancer, or prevent disease progression elsewhere. Some patients continue to need nutritional supplements or enteral feeding. If the tumor extends across the lower esophageal sphincter, reflux may become troublesome, while lesions near the upper esophageal sphincter can cause coughing, chest discomfort, or a sensation of a foreign body.
| Consideration | Esophageal stent | Palliative radiotherapy | Feeding access |
|---|---|---|---|
| Speed of swallowing relief | Usually rapid | Often delayed | Does not restore swallowing |
| Main purpose | Open an obstruction | Reduce tumor-related symptoms | Provide nutrition and hydration |
| Invasiveness | Endoscopic procedure | External treatment sessions | Endoscopic or surgical placement |
| Common limitations | Migration, reflux, pain, reintervention | Treatment delay and fatigue | Tube care and reduced oral intake |
| Best fit | Immediate dysphagia relief or fistula control | Longer-term local symptom management | Unsafe swallowing or severe malnutrition |
Chest pain and temporary discomfort are common after expansion, particularly during the first few days. Reflux, regurgitation, bleeding, aspiration, and stent migration can occur. Less frequent but serious complications include perforation, major hemorrhage, airway compression, and fistula formation.
Tumor overgrowth at either end of the device may cause recurrent swallowing difficulty. Tumor ingrowth through an uncovered portion can have a similar effect. A patient who develops worsening dysphagia, persistent vomiting, fever, severe chest pain, black stools, or breathing difficulty needs urgent medical assessment.
Follow-up should include review of swallowing, hydration, weight, pain, reflux, and respiratory symptoms. Dietary guidance is important: many patients begin with liquids, progress to soft foods, take small bites, chew thoroughly, and remain upright after meals. Exact instructions must come from the treating team.
Palliative radiotherapy may provide durable relief when the patient can wait for treatment to take effect and has a performance status that permits repeated visits. Endoscopic tumor debulking or dilation may help selected patients, but dilation alone often provides only temporary benefit and can carry perforation risk.
A feeding tube may be preferable when swallowing is unsafe, aspiration risk is high, or the tumor’s location makes stenting unsuitable. Some patients need both a stent and supplemental enteral nutrition. Decisions should reflect expected survival, nutritional status, symptom severity, prior treatments, and the person’s wishes.
For tumors close to the airway, bronchoscopy or imaging may be needed before intervention. A multidisciplinary plan can reduce the risk of placing a device that worsens respiratory symptoms or complicates another essential treatment.
Stent placement should be discussed as part of a broader comfort-focused care plan rather than as an isolated procedure. Clinicians can explain the likely speed of benefit, possible need for reintervention, dietary restrictions, and what symptoms require emergency care.
Important points to review include:
Clear communication is especially important when prognosis is limited. The best intervention is the one that offers meaningful relief while matching the patient’s tolerance for procedures, follow-up, and possible complications.
Esophageal stents remain an important tool in supportive oncology and endoscopic palliation. Specialist education, evidence-based device selection, and coordinated follow-up can help teams use them safely and appropriately. Explore the educational resources and scientific program materials associated with ISDE to deepen understanding of esophageal disease management and multidisciplinary palliative care.